Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

React to this article
1d ago AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
3d ago AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
4d ago AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
4d ago AUXILIUM PHARMACEUTICALS : Reports Stockholders Special Meeting
12/12 AUXILIUM PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form..
12/11 AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
12/04 AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
12/03 AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
11/26 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
11/26 AUXILIUM PHARMACEUTICALS : "Method of Treating Or Reducing EFP" in Patent Applic..
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes